Because adenine synthesis can only be maintained by de novo biosynthesis in MTAP deficient cancer cells, inhibition of critical enzymes for folate synthesis terminated MTAP deficient cancer cells in experimental models and also showed in vivo anti-cancer efficiency in urinary bladder cancer patients4. The gene discussed is MTAP; the disease is urinary bladder cancer.